Patent · US Active

Self-gelling alginate systems and uses thereof

US7790699B2 · kind B2 · utility

62Cited by
23References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 12, 2005
Grant dateSep 7, 2010
Priority date
Expiry dateJul 18, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Kits and compositions for producing an alginate gel are disclosed. The kits and compositions comprise soluble alginate and insoluble alginate/gelling ion particles. Methods for dispensing a self-gelling alginate dispersion are disclosed. The methods comprise forming a dispersion of insoluble alginate/gelling ion particles in a solution containing soluble alginate, and dispensing the dispersion whereby the dispersion forms an alginate gel matrix. The methods may include dispensing the dispersion into the body of an individual. An alginate gel having a thickness of greater than 5 mm and a homogenous alginate matrix network and homogenous alginate gels free of one or more of: sulfates citrates, phosphates, lactatates, EDTA or lipids are disclosed. Implantable devices comprising a homogenous alginate gel coating are disclosed. Methods of improving the viability of pancreatic islets, or other cellular aggregates or tissue, following isolation and during storage and transport are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.